Publication:
Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers.

dc.contributor.authorFernández-Ginés, F Dámaso
dc.contributor.authorCortiñas-Sáenz, Manuel
dc.contributor.authorAgudo-Ponce, Desirée
dc.contributor.authorNavajas-Gómez de Aranda, Ana
dc.contributor.authorMorales-Molina, José A
dc.contributor.authorFernández-Sánchez, Carmen
dc.contributor.authorSierra-García, Francisco
dc.contributor.authorMateo-Carrasco, Héctor
dc.date.accessioned2023-02-08T14:37:46Z
dc.date.available2023-02-08T14:37:46Z
dc.date.issued2019-11-25
dc.description.abstractRecently, it has been reported that topical irrigations of liquid sevoflurane on the bed of painful wounds produce a rapid, intense, and lasting analgesic effect. In this paper, A cohort of 112 patients with painful pressure ulcers who were refractory to opioids (or who exhibited undesirable adverse events to them) was treated with topical sevoflurane as per local institutional policy. These patients were recruited from an intensive care unit for a period of 3 years. The main aim was to determine the effectiveness of topical sevoflurane in reducing the pain of PUs and reducing the ulcer area. Study findings are reported and discussed herein and suggest that sevoflurane is a viable and promising treatment option for PUs.
dc.identifier.doi10.1111/iwj.13235
dc.identifier.essn1742-481X
dc.identifier.pmcPMC7948686
dc.identifier.pmid31762163
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948686/pdf
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/iwj.13235
dc.identifier.urihttp://hdl.handle.net/10668/14738
dc.issue.number1
dc.journal.titleInternational wound journal
dc.journal.titleabbreviationInt Wound J
dc.language.isoen
dc.organizationHospital Torrecárdenas
dc.organizationHospital Torrecárdenas
dc.organizationHospital Torrecárdenas
dc.organizationHospital Torrecárdenas
dc.page.number83-90
dc.pubmedtypeComparative Study
dc.pubmedtypeJournal Article
dc.pubmedtypeObservational Study
dc.rights.accessRightsopen access
dc.subjectopioid
dc.subjectpain
dc.subjectpressure ulcer
dc.subjectsevoflurane
dc.subjecttopical treatment
dc.subject.meshAdministration, Intravenous
dc.subject.meshAdministration, Topical
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAnalgesics, Opioid
dc.subject.meshCohort Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPain
dc.subject.meshPlatelet Aggregation Inhibitors
dc.subject.meshPressure Ulcer
dc.subject.meshProspective Studies
dc.subject.meshSevoflurane
dc.subject.meshSpain
dc.titlePain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication

Files